Sarlósejtes vérszegénység: vizsgálatok itt: Spanyolország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleIntegrative Diagnosis for SCD and Other RADs
- Where
- Barcelona, Esplugues de Llobregat, Madrid
- People
- 350
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07206095 - 3. fázisTaking peopleThe Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Where
- Madrid
- Életkor
- 10 év to 65 év
- People
- 192 worldwide
- Run by
- Sanofi
See details and how to joinNCT06975865 - 2. fázisBefejeződöttSafety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Where
- Barcelona, Esplugues de Llobregat, Madrid, Sevilla
- Életkor
- 12 év and over
- People
- 70 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06699849 · EU 2024-513440-29-00 - 3. fázisNot yet taking people in SpanyolországA research study to evaluate how well etavopivat works in children with sickle cell disease
- Where
- Barcelona, Madrid, Zaragoza
- Életkor
- Up to 17 év
- People
- 27 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2025-524464-38-00 - 3. fázisTaking peopleA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Barakaldo, Barcelona, Madrid
- Életkor
- 2 év and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - 3. fázisTaking peopleA Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Where
- Barcelona, Madrid, Sevilla
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00 - 2/3. fázisNot yet taking people in SpanyolországA Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Where
- Barakaldo, Barcelona, Madrid
- Életkor
- 12 év to 64 év
- People
- 389 worldwide
- Run by
- Pfizer
See details and how to joinNCT05431088 · EU 2023-508766-14-00 - 1. fázisTaking peopleStudy of IADADEMSTAT for the Treatment of Sickle Cell Disease.
- Where
- Badalona, Barcelona, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 39
- Run by
- Oryzon Genomics S.A.
See details and how to join2025-521838-29-00 - 4. fázisFut, nem toborozRollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Where
- Barcelona, Madrid
- Életkor
- 6 hónap to 100 év
- People
- 130 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04657822 · EU 2024-510734-41-00 - No phaseNot yet taking people in SpanyolországStudy of the Role of Genetic Modifiers in Hemoglobinopathies
- Where
- Madrid
- Életkor
- 2 év and over
- People
- 30 000 worldwide
- Run by
- Cyprus Institute of Neurology and Genetics
See details and how to joinNCT05799118 - No phaseTaking peopleEuropean Rare Blood Disorders Platform (ENROL)
- Where
- Barcelona
- Életkor
- Up to 100 év
- People
- 37 090
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT06250595 - No phaseTaking peopleRADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
- Where
- Barcelona
- Életkor
- 0 év to 100 év
- People
- 32 564
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT06213402